Lion Point Capital, LP Portfolio Holdings

Lion Point Capital, LP

  • $10.5 Million
  • Q3 2025

Lion Point Capital, LP has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $10.5 Million distributed in 27 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Milestone Pharmaceuticals Inc. with a value of $1.31M, Fennec Pharmaceuticals Inc. with a value of $1.13M, Insmed Inc with a value of $900K, Ardelyx, Inc. with a value of $898K, and Syndax Pharmaceuticals Inc with a value of $846K.

Examining the 13F form we can see an increase of $1.64M in the current position value, from $8.91M to 10.5M.

Lion Point Capital, LP is based out at New York, NY

Below you can find more details about Lion Point Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $10.5 Million
Healthcare: $10.5 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 27
  • Current Value $10.5 Million
  • Prior Value $8.91 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 9 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Lion Point Capital, LP Portfolio

Follow Lion Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lion Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Lion Point Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email